Skip to content

Clinical trials

Phase 1/2 Macular Degeneration trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Phase: Phase 1/2 Clear all

71 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20043
20051
20061
20071
20083
20095
20103
20115
20123
20132
20144
20158
20161
20184
20191
20201
20214
20222
20234
20244
20252
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40
Unknown status11
Recruiting8
Terminated7
Active, not recruiting3
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Eye Institute (NEI)3
Santen Inc.3
Catholic University of the Sacred Heart2
Chengdu Origen Biotechnology Co., Ltd.2
Hoffmann-La Roche2
Perceive Biotherapeutics, Inc.2
4D Molecular Therapeutics1
AbbVie1
Ace Cells Lab Limited1
Acuity Medical International, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration71
Geographic Atrophy10
Retinal Diseases10
Choroidal Neovascularization8
Eye Diseases8
Retinal Degeneration6
Wet Macular Degeneration4
Stargardt Disease3
Diabetic Retinopathy2
Glycogen Storage Disease Type II2

Trials

Showing 26 to 50 of 71. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.